Welcome to our survey regarding staging and management of the axilla in neoadjuvant era!
Thank you for agreeing to take part in this survey. Following the AXISS (Axillary Survey study) survey on the axillary treatment of SN-positive breast cancer patients, this survey focuses on breast cancer with nodal positivity confirmed at diagnosis (cN+ patients). Our aim is to gain information on current practices for axillary staging and management of cN+ patients receiving neoadjuvant chemotherapy (NAC). We will survey the diagnostic work-up, axillary mapping and opinions on omitting axillary lymph node dissection (ALND).
The survey consists of three parts and will take approximately 5-10 minutes of your time. Be assured that all answers you provide will be kept in the strictest confidentiality.
We look forward to a close collaboration with you and we appreciate your feedback on this survey.
Welcome on board!
Sabrina Maaskant-Braat and Marjolein Smidt, Principal Investigators
Janine Simons, PhD student
Cornelis van de Velde
Carmen van der Pol
Thiemo van Nijnatten
RISAS Study Team (NCT02800317 at ClinicalTrials.gov)